Pharsight

Drugs that contain Darunavir

1. Prezista patents expiration

PREZISTA's oppositions filed in EPO
PREZISTA Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US8518987 JANSSEN PRODS Pseudopolymorphic forms of a HIV protease inhibitor
Feb, 2024

(8 days ago)

US7700645 JANSSEN PRODS Pseudopolymorphic forms of a HIV protease inhibitor
Dec, 2026

(2 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8518987

(Pediatric)

JANSSEN PRODS Pseudopolymorphic forms of a HIV protease inhibitor
Aug, 2024

(5 months from now)

US7700645

(Pediatric)

JANSSEN PRODS Pseudopolymorphic forms of a HIV protease inhibitor
Jun, 2027

(3 years from now)

Market Authorisation Date: 23 June, 2006

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of PREZISTA before it's drug patent expiration?
More Information on Dosage

PREZISTA family patents

Family Patents